FGF-R4 receptor-specific antagonists

Details for Australian Patent Application No. 2009267834 (hide)

Owner SANOFI-AVENTIS

Inventors Blanche, Francis; Berne, PierreFrancois; Dabdoubi, Tarik; Baurin, Nicolas; Bono, Francoise; Remy, Elisabeth; Herbert, Corentin; Cameron, Beatrice; Mikol, Vincent

Agent A J Park

Pub. Number AU-A-2009267834

PCT Pub. Number WO2010/004204

Priority 08/03888 08.07.08 FR

Filing date 7 July 2009

Wipo publication date 14 January 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/004204 Priority application(s): WO2010/004204

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009267844-Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer

2009267828-Antineoplastic derivatives of 4-OXO-L, 4-dihydro-quinoline, preparation thereof, and therapeutic use thereof